Liver function and drug processing: a new study
NCT ID NCT06336018
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 21 times
Summary
This study looks at how the body handles a single dose of the experimental drug etavopivat in people with mild, moderate, or severe liver problems compared to those with healthy livers. 48 adults took one pill by mouth and were monitored for about a week. The goal is to understand safety and how the drug moves through the body, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Amer. Rrsch Corp-TX Liver Inst
San Antonio, Texas, 78215, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32806, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.